NCT04200404 2022-05-06A Study of CS1001 in Combination With Regorafenib in Patients With Advanced or Refractory Solid TumorsCStone PharmaceuticalsPhase 1/2 Completed19 enrolled
NCT02466802 2020-02-20Study of Regorafenib and Sildenafil for Advanced Solid TumorsVirginia Commonwealth UniversityPhase 1 Completed32 enrolled